The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
Thousands of people have linked hands on Westminster Bridge in a show of solidarity - one week after the terror attack in the capital.
PC Keith Palmer, 48, stabbed by Khalid Masood while on duty in the grounds of the Palace of Westminster last Wednesday.
Engineering firm CH2M won the £170 million contract but have pulled out of phase two of the project over alleged conflicts of interest.